Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) EPS (Basic): 2010-2025

Historic EPS (Basic) for OptimizeRx (OPRX) over the last 16 years, with Q3 2025 value amounting to $0.04.

  • OptimizeRx's EPS (Basic) rose 10800.0% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.04, marking a year-over-year increase of 10800.0%. This contributed to the annual value of -$1.1 for FY2024, which is 679.61% down from last year.
  • OptimizeRx's EPS (Basic) amounted to $0.04 in Q3 2025, which was up 10800.0% from $0.08 recorded in Q2 2025.
  • Over the past 5 years, OptimizeRx's EPS (Basic) peaked at $0.26 during Q4 2024, and registered a low of -$0.5 during Q3 2024.
  • In the last 5 years, OptimizeRx's EPS (Basic) had a median value of -$0.17 in 2023 and averaged -$0.13.
  • As far as peak fluctuations go, OptimizeRx's EPS (Basic) crashed by 850095.19% in 2022, and later surged by 20746.41% in 2024.
  • Over the past 5 years, OptimizeRx's EPS (Basic) (Quarter) stood at $0.03 in 2021, then plummeted by 166.67% to -$0.02 in 2022, then tumbled by 1100.0% to -$0.24 in 2023, then skyrocketed by 207.46% to $0.26 in 2024, then crashed by 84.49% to $0.04 in 2025.
  • Its EPS (Basic) stands at $0.04 for Q3 2025, versus $0.08 for Q2 2025 and -$0.12 for Q1 2025.